coronaviru
diseas
pandem
caus
sever
acut
respiratori
syndrom
coronaviru
pose
global
threat
diseas
sever
vari
wide
mild
requir
hospit
death
grow
number
us
case
expect
tax
capac
health
care
deliveri
system
analysi
clinic
characterist
time
patient
present
associ
diseas
sever
immedi
use
recogn
rapid
util
data
evalu
clinic
characterist
diseas
cours
patient
confirm
stanford
hospit
approv
stanford
institut
review
board
patient
chart
analyz
diagnos
rtpcr
receiv
care
stanford
hospit
march
past
medic
histori
document
statist
analys
conduct
microsoft
excel
r
patient
analyz
median
age
year
iqr
rang
male
inpati
outpati
tabl
base
chart
document
past
medic
histori
hypertens
hyperlipidemia
diabet
type
type
consist
previou
report
common
prediagnosi
comorbid
patient
hypertens
rate
significantli
differ
us
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
preval
fisher
exact
test
p
angiotensinconvert
enzym
inhibitor
acei
angiotensin
ii
receptor
blocker
arb
use
patient
also
significantli
differ
us
preval
fisher
exact
test
p
univari
analysi
age
lower
oxygen
satur
initi
examin
hypertens
significantli
associ
recommend
hospit
care
lower
oxygen
satur
associ
admiss
icu
age
lower
oxygen
satur
associ
diagnosi
pneumonia
lower
oxygen
satur
hypertens
assoc
progress
acut
respiratori
distress
syndrom
ard
tabl
use
acei
arb
significantli
associ
recommend
hospit
care
admiss
icu
diagnosi
pneumonia
progress
ard
analyz
logist
regress
control
age
factor
independ
significantli
associ
recommend
inhospti
care
diagnosi
pneumonia
progress
ard
initi
oxygen
satur
measur
continu
variabl
clinic
characterist
us
patient
factor
initi
present
associ
diseas
sever
identifi
lower
oxygen
satur
present
independ
significantli
associ
measur
diseas
sever
thu
may
serv
use
indic
potenti
diseas
progress
addit
histori
hypertens
predispos
patient
wors
outcom
ard
although
independ
age
consist
previou
report
sever
factor
includ
agerel
chang
immun
system
physiolog
process
could
contribut
diseas
sever
hypertens
associ
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
morbid
independ
age
thu
studi
need
elucid
extent
hypertens
andor
dysregul
reninangiotensinaldosteron
system
raa
contribut
pathogenesi
idea
raa
dysregul
may
influenc
diseas
progress
warrant
explor
use
acei
andor
arb
therapi
manag
potenti
role
raa
system
pathogenesi
stem
mount
sequenc
structur
evid
indic
entri
via
interact
spike
protein
human
host
receptor
angiotensinconvert
enzym
difficult
predict
effect
raa
blockad
treatment
may
increas
express
known
antiinflammatori
pulmonari
protect
properti
yet
simultan
promot
viral
entri
howev
raa
blockad
may
also
increas
solubl
could
serv
decoy
receptor
protect
viral
entri
studi
histori
acei
arb
use
affect
diagnosi
rate
predispos
patient
wors
diseas
outcom
howev
studi
underpow
draw
definit
conclus
neg
data
hope
initi
find
motiv
larger
studi
intend
character
raa
blockad
set
limit
studi
includ
lack
data
diseas
progress
due
retrospect
design
potenti
select
bia
patient
sever
diseas
like
test
extens
chart
howev
us
data
immedi
clinic
relev
given
rapidli
evolv
pandem
help
clinician
identifi
treat
patient
risk
sever
diseas
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
